Why the study?
Does ouabain-induced ventricular tachycardia alter oxygen consumption and metabolism in the dog heart?
Does ouabain-induced ventricular tachycardia alter oxygen consumption and metabolism in the dog heart?
In a dog heart-lung model, ouabain-induced ventricular tachycardia increases oxygen demand without depleting high-energy phosphates as long as hypoxia is avoided.
Hypothesis-generating for arrhythmia energetics; leaves open any clinical relevance in human tachycardia.
At constant pressure work there was an increase in the oxygen consumption of the dog heartlung preparation after tachycardia due to auricular stimulation and a far greater increase in consumption after ouabain-induced ventricular tachycardia, as compared with control hearts beating at their own sinus rhythm. In neither condition was the increase in coronary flow greater than the spontaneous increase in the controls. It is suggested that an increase in oxygen demand, under certain circumstances, may be met primarily by an increased desaturation of coronary blood. "Therapeutic" doses of ouabain did not improve the mechanical efficiency of the preparation. "Toxic" doses of ouabain which gave rise to ventricular tachycardia did not decrease the phosphocreatine or labile nucleotide phosphorus content of the heart provided there was no hypoxia of the heart muscle.
No takes yet. Share an insight, caveat, or question.
Fawaz et al. (1959) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: